We demonstrate that hCMEC/D3 cells treated with tumor EVs carrying Valosin-Containing Protein (VCP) have a distinct VEGFR2 phosphorylation, while VCP modulation in hCMEC/D3 cells by transfection resulted in changes in barrier properties. The gene discussed is VCP; the disease is neoplasm.